(Q44660500)

5 December 2017

title

Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas (English)

1 reference

5 December 2017

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

3 April 2024

author name string

A. Giatromanolaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624781

3 April 2024

M. I. Koukourakis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624781

3 April 2024

C. Simopoulos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624781

3 April 2024

A. Polychronidis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624781

3 April 2024

E. Sivridis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624781

3 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14624781

3 April 2024

publication date

1 December 2003

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S0748798303002142?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

https://api.elsevier.com/content/article/PII:S0748798303002142?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

European Journal of Surgical Oncology

3 April 2024

published in

1 reference

5 December 2017

volume

29

1 reference

5 December 2017

issue

10

1 reference

5 December 2017

page(s)

879-883

1 reference

The biology of vascular endothelial growth factor

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Anti-angiogenic agents: clinical trial design and therapies in development

3 April 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance

3 April 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe

3 April 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Carcinoma of the gallbladder. Does radical resection improve outcome?

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Primary carcinoma of the gall-bladder: potential for external radiation therapy.

3 April 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases

3 April 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Primary carcinoma of the gallbladder. Adjuvant postoperative external irradiation

3 April 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1

3 April 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Thymidine phosphorylase expression in gallbladder adenocarcinomas

3 April 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Prognostic role of angiogenesis in operable carcinoma of the gallbladder.

3 April 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Tumor angiogenesis in gallbladder carcinoma

3 April 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

3 April 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer

3 April 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer.

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJSO.2003.09.013

3 April 2024

Identifiers

1 reference

5 December 2017

1 reference